CYANOTECH CORP (CYAN) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US2324373016

Price
0.61 USD
Market cap
4.45 m USD
P/E (2026)
–
P/S (2026)
0.17
Dividend yield
0.00 %
Net margin
-4.82 %
Return on equity (ROE)
-16.74 %
Return on assets (ROA)
-5.79 %

CYANOTECH CORP financials

Fiscal year20252026
Revenue24.22 m USD26.59 m USD
Gross profit6.88 m USD8.67 m USD
Operating income-2.51 m USD-574,000.00 USD
EBIT-2.51 m USD–
Net income-3.20 m USD-1.28 m USD
Diluted EPS – continuing operations–-0.18 USD

Full history since 1990, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About CYANOTECH CORP

Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction, and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. It operates in the United States, the Asia-Pacific, Europe, and internationally. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.